Search Results - "Itakura, Hitoe"

Patient and family burden in pediatric atopic dermatitis and its treatment pattern in Japan by Otsuka, Atsushi, Wang, Chaochen, Torisu‐Itakura, Hitoe, Matsuo, Takashi, Isaka, Yoshitaka, Anderson, Peter, Piercy, James, Austin, Jenny, Marwaha, Simran, Tanaka, Akio

“…Background This study evaluated the level of burden in pediatric and adolescent atopic dermatitis (AD) patients in Japan, the associated burden on…”
Get full text

Efficacy and safety of ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis: Subgroup analysis of a placebo‐controlled, phase 3 study (UNCOVER‐1) by Imafuku, Shinichi, Torisu‐Itakura, Hitoe, Nishikawa, Atsushi, Zhao, Fangyi, Cameron, Gregory S.

“…The present study describes a subgroup analysis of 33 Japanese patients participating in UNCOVER‐1, an international, placebo‐controlled, phase 3 study of…”
Get full text

Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan by Okubo, Yukari, Tang, Ann Chuo, Inoue, Sachie, Torisu-Itakura, Hitoe, Ohtsuki, Mamitaro

“…Previously, our cross-sectional observational study in Japan revealed high (68%) discordance within treatment goals between psoriasis patients and their…”
Get full text

Treatment practices and costs among patients with psoriatic arthritis: A Japanese hospital claims database analysis by Inui, Kentaro, Sato, Masayo, Esterberg, Elizabeth, Parikh, Rohan C., Kimura, Shuichi, Torisu-Itakura, Hitoe

“…Assess patient characteristics, real-world treatment patterns, and health care resource utilization (HCRU) among patients with psoriatic arthritis (PsA) in…”
Get full text

Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy by Costanzo, Antonio, Tanaka, Akio, Torres, Tiago, Pérez‐García, Bibiana, Sontag, Angelina, Chen, Yun‐Fei, Yang, Fan Emily, Kolodsick, Jill, Torisu‐Itakura, Hitoe, Somani, Najwa

“…Background The Janus kinase (JAK)1/JAK2 inhibitor baricitinib in combination with topical corticosteroids (TCS) improved moderate‐to‐severe atopic dermatitis…”
Get full text

Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial by Flaherty, Devin C., DO, PhD, Lavotshkin, Simon, MD, Jalas, John R., MD, PhD, Torisu-Itakura, Hitoe, MD, PhD, Kirchoff, Daniel D., MD, Sim, Myung S., PhD, Lee, Delphine J., MD, PhD, Bilchik, Anton J., MD, PhD, FACS

“…Abstract Background Retrospective data indicate that immunoprofiling of T cell markers may be prognostic in colon cancer. Prospective T cell immunoprofiling of…”
Get full text

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis by Tanaka, Akio, Igawa, Ken, Takahashi, Hidetoshi, Shimizu, Ryosuke, Kataoka, Yoko, Torisu-Itakura, Hitoe, Morisaki, Yoji, Montmayeur, Sonia, Katoh, Norito

“…Lebrikizumab has previously demonstrated efficacy in Phase 3 trials: ADvocate1 and ADvocate2 (as monotherapy), ADhere, and ADhere-J (in combination with…”
Get full text

Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study by Wang, Chaochen, Torisu-Itakura, Hitoe, Hanada, Takao, Matsuo, Takashi, Cai, Zhihong, Osaga, Satoshi, Aranishi, Toshihiko

“…Real-world evidence on persistence of interleukin-17 inhibitors (IL-17i) as a drug class among Japanese patients with psoriasis is lacking. Hence, we aimed to…”
Get full text

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J) by Honma, Masaru, Cai, Zhihong, Burge, Russel, Zhu, Baojin, Yotsukura, Sohiya, Torisu-Itakura, Hitoe

“…Introduction Ixekizumab has demonstrated rapid onset of action, high levels of skin clearance, and improvements in quality of life in patients with…”
Get full text

Co‐expression of Thymidine Phosphorylase and Heme Oxygenase‐1 in Macrophages in Human Malignant Vertical Growth Melanomas by Torisu‐Itakura, Hitoe, Furue, Masutaka, Kuwano, Michihiko, Ono, Mayumi

“…Expression of thymidine phosphorylase (TP) is often associated with tumor angiogenesis and/or prognosis in patients. Further, infiltration of macrophages is…”
Get full text

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan by Macey, Jake, Kitchen, Helen, Aldhouse, Natalie V. J., Burge, Russel T., Edson-Heredia, Emily, McCollam, Jill S., Isaka, Yoshitaka, Torisu-Itakura, Hitoe

“…Introduction The content validity and treatment success thresholds of clinical outcome assessments (COAs) for alopecia areata (AA)—including the Alopecia…”
Get full text

Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma by LEE, Jonathan H, ESSNER, Richard, TORISU-ITAKURA, Hitoe, WANEK, Leslie, HEJING WANG, MORTON, Donald L

“…Approximately 20% of sentinel node (SN) positive melanoma patients have additional non-SN (NSN) metastasis. The rationale for this study was to identify the…”
Get full text

51075 HADS anxiety and depression scores improved in Japanese patients with moderate-to-severe atopic dermatitis following lebrikizumab treatment: 16-week results from a randomized, double-blind, placebo-controlled phase 3 trial (ADhere-J) by Nakahara, Takeshi, Tsunemi, Yuichiro, Torisu-Itakura, Hitoe, Morisaki, Yoji, Pierce, Evangeline, Dossenbach, Martin, Saeki, Hidehisa

Get full text

Molecular Characterization of Inflammatory Genes in Sentinel and Nonsentinel Nodes in Melanoma by TORISU-ITAKURA, Hitoe, LEE, Jonathan H, SCHERI, Randall P, HUYNH, Young, XING YE, ESSNER, Richard, MORTON, Donald L

“…Purpose: Identification of regional node metastasis is important for accurate staging and optimal treatment of early melanoma. We hypothesize that the nodal…”
Get full text

48964 Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-Severe Atopic Dermatitis by Tanaka, Akio, Igawa, Ken, Takahashi, Hidestoshi, Shimizu, Ryoshuke, Kataoka, Yoko, Torisu-Itakura, Hitoe, Morisaki, Yoji, Montmayeur, Sonia, Katoh, Norito

Get full text

Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J) by Katoh, Norito, Tanaka, Akio, Takahashi, Hidetoshi, Shimizu, Ryosuke, Kataoka, Yoko, Torisu-Itakura, Hitoe, Morisaki, Yoji, Yamamoto, Chie, Igawa, Ken

“…Moderate-to-severe atopic dermatitis (AD) impacts patients' quality of life (QOL). More treatment options are urgently needed to manage this chronic disease…”
Get full text

Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients by Torisu-Itakura, Hitoe, Anderson, Peter, Piercy, James, Pike, James, Sakamoto, Atsushi, Kabashima, Kenji

“…Patients with atopic dermatitis experience a broad range of symptoms, including both itch and skin pain, however it is not clear how these symptoms combine to…”
Get full text

41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata by Shapiro, Jerry, Ko, Justin, Egeberg, Alexander, Somani, Najwa, Jedynak, Jakub, Torisu-Itakura, Hitoe, Yu, Guanglei, Lu, Na, Craiglow, Brittany

Get full text

Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians - Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levels by Okubo, Yukari, Torisu-Itakura, Hitoe, Hanada, Takao, Aranishi, Toshihiko, Inoue, Sachie, Ohtsuki, Mamitaro

“…High treatment satisfaction in both patients and physicians is an important factor in improving quality of life in psoriasis patients. This study aimed to…”
Get full text

Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis by Morita, Akimichi, Okubo, Yukari, Morisaki, Yoji, Torisu-Itakura, Hitoe, Umezawa, Yoshinori

“…Introduction In 2018, ixekizumab (80 mg every 2 weeks [Q2W] beyond Week 12) received approval in Japan for patients with generalized pustular psoriasis (GPP)…”
Get full text